The establishment of the African Medicines Agency (AMA) will significantly contribute to the improvement of healthcare delivery across the continent and better overall health of African citizens. Africa continues to be a growing continent in many aspects. It is expected that the population of young Africans...
Pretoria, 06 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is currently conducting a Stakeholder Satisfaction Survey through an independent market research agency, MarkData (Pty) Ltd. SAHPRA has commissioned MarkData to conduct these surveys to better understand its effectiveness in implementing its regulatory...
SAHPRA offices will be closed for the festive season from 12:00 on Friday, 22 December 2023 and will re-open on Tuesday, 02 January 2024. Submissions to SAHPRA New Medicine, Variation, License, Renewal Applications Applications/submissions must reach SAHPRA by 14 December 2023 at 13:00 to allow for the administrative...
This workshop will provide an exchange of information and capacity building between the South African Health Products Regulatory Authority, SAPHRA and partner reference NRAs including the WHO, USFDA, TGA, HSA, ANVISA, covering the core international references for medical device regulatory. The workshop objective is to...
Pretoria, 06 November 2023 – The South African Health Products Regulatory Authority (SAHPRA) is urging patients, doctors, nurses, or pharmacists to play their part in reporting side effects using the MedSafety app. Reporting side effects is key to helping make medicines safer for the population...
The South African Health Products Regulatory Authority (SAHPRA) is commemorating the #MedSafetyWeek2023 campaign, in collaboration with South African Pharmacy Council (SAPC), by hosting a webinar focused on the Importance of Reporting Adverse Events. The #MedSafetyWeek is an international social media campaign organised every year by the Uppsala Monitoring...
The Radiation Control (RadCon) Unit of the South African Health Products Regulatory Authority (SAHPRA) hosted an informational webinar to increase awareness and understanding of radiation control regulatory processes. You have an opportunity to learn and engage with SAHPRA colleagues on key regulatory compliance processes within the...
The South African Health Products Regulatory Authority (SAHPRA) has launched its very own chatbot, Reggie. Reggie is here to help you find information on the website more easily. How do you use the chatbot?Simply type in a keyword or ask Reggie a question. He is quick...
Pretoria, 26 October 2023 – The South African Health Products Regulatory Authority (SAHPRA) currently has four (4) COVID-19 vaccines which are under review, the COMIRNATY Bivalent paediatric and adult vaccines, mRNA (COMIRNATY Bivalent Infant DTU vaccine), and non-mRNA vaccine Coviccine. SAHPRA has so far registered three...
Pretoria, 10 October 2023 –The South African Health Products Regulatory Authority (SAHPRA) participated in a Carte Blanche media interview on an ongoing investigation into the illicit bulk sale of codeine-based cough mixtures. This investigative report was broadcast on Sunday, 08 October 2023. The report relates to...
